📋 FDA Reference

Sdr 3500 Philips Platinum

Philips Ultrasound

Compare similar devices

Summary: The SDR 3500 Philips Platinum is an ultrasound device used for diagnostic imaging, primarily by radiologists and other imaging specialists. It aids in visualizing internal structures and is commonly used in hospitals and clinics.

FDA Clearance Information

Pathway ? 510(k)
Number ? K873937 ↗
Decision Date ? March 23, 1988
Product Code ? IYO
Device Class ? Class 2
Evidence ? 419 studies

The SDR 3500 Philips Platinum was cleared through the FDA 510(k) pathway on March 23, 1988. Manufactured by Philips Ultrasound, it is classified as a Class 2 device under product code IYO.

What It Is

The SDR 3500 Philips Platinum is an ultrasound imaging device designed to provide high-resolution images of internal body structures. It operates by emitting sound waves that reflect off tissues, creating detailed images for diagnostic purposes. This device is part of Philips' line of advanced imaging solutions, known for their reliability and precision in clinical settings.

FDA-Cleared Indications

  • Diagnostic ultrasound imaging of internal anatomical structures.
  • Evaluation of tissues and organs using reflected ultrasound waves.
  • Noninvasive imaging to support the diagnosis and monitoring of disease.

Clinical Applications

  • Ultrasound imaging of abdominal and pelvic organs.
  • Imaging of superficial soft tissues and masses.
  • Ultrasound evaluation of blood vessels when used with an appropriate compatible transducer.
  • Obstetric imaging when supported by the applicable system labeling and transducer.
  • Cardiac imaging when supported by the applicable system labeling and transducer.

Reported off-label uses

  • Ultrasound guidance for bedside procedures such as vascular access.
  • Point-of-care assessment of fluid collections or free fluid.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Practical Considerations

  • Use only compatible transducers, accessories and software identified by the manufacturer or facility biomedical engineering department.
  • Image quality depends on transducer selection, patient factors, operator technique, calibration and preventive maintenance.
  • Ultrasound does not use ionizing radiation and is not an MRI device; it should not be placed in the MRI scanner or MRI-controlled area unless specifically approved for that environment.
  • Contraindications and precautions depend on the examination, acoustic output, transducer and patient condition; follow the system operator manual and current ultrasound safety guidance.
  • The FDA record identifies the device as a Class II device cleared through 510(k) K873937 in 1988 under product code IYO; detailed original specifications should be confirmed from Philips documentation.

Linked Studies (20)

PubMed • 2025

Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.

Journal of neuroendovascular therapy

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.

Clinical chemistry and laboratory medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical progress note: Haemophilus influenzae type b.

Journal of hospital medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Pilot study of social media promotion of home-based self-testing for syphilis.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.

Journal of clinical microbiology

View Source →
PubMed • 2025

Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.

Florida public health review

View Source →
PubMed • 2025

Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.

Frontiers in cellular and infection microbiology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.

Transboundary and emerging diseases

View Source →
PubMed • 2025

Tp40: a new potential prognostic and diagnostic marker for syphilis.

Microbiology spectrum

View Source →
PubMed • 2025

Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.

The Journal of clinical investigation

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.

Hellenic journal of nuclear medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.

Biochemistry and cell biology = Biochimie et biologie cellulaire

View Source →
PubMed • 2025

Editorial - Philippe Ascher (1936-2022).

Neuroscience

View Source →
PubMed • 2025

Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.

Journal of Yeungnam medical science

RCT View Source →
PubMed • 2025

pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.

Magnetic resonance in medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Comparative connectomics of Drosophila descending and ascending neurons.

Nature

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences

View Source →
PubMed • 2025

History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.

Zeitschrift fur Rheumatologie

View Source →
PubMed • 2025

A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.

BioMed research international

RCT|prospective|retrospective|case Series|other View Source →

Frequently Asked Questions

What is the SDR 3500 Philips Platinum used for?

The SDR 3500 Philips Platinum is used for diagnostic ultrasound imaging to visualize internal body structures, aiding in the diagnosis and monitoring of various medical conditions.

What specialties typically use this device?

Specialties that typically use this device include radiology, cardiology, obstetrics, and general surgery, among others.

What are the FDA-cleared indications?

The device is indicated for use in diagnostic imaging to evaluate and monitor conditions affecting internal organs and tissues, providing non-invasive anatomical visualization.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you